2017 Primary Changes and Updates in Recommendations

CDC's Advisory Committee on Immunization Practices (ACIP) has again decided to recommend against use of live attenuated influenza vaccine (LAIV; FluMist) for the 2017-2018 flu season because of the vaccine's reduced efficacy.  You can read the official recommendations from ACIP for the 2017-2018 flu season here. The ACIP continues to recommend annual flu vaccination with inactive influenza vaccine (IIV) or recombinant influenza vaccine (RIV) for everyone 6 months and older. See this list of approved influenza vaccines for more information.

Children aged 6 months through 8 years who are receiving influenza vaccine for the first time, and some in this age group who have previously been vaccinated, require two doses of vaccine administered ≥4 weeks apart. For more information and an algorithm for dosing  in this age group visit 2017-18 ACIP guidelines.

The 2017-18 ACIP Guidelines have updated recommendations regarding the vaccination of persons with egg allergies. Persons with a history of egg allergy who have experienced only hives after exposure to egg and non-allergic persons should be watched for 15 minutes following vaccination to decrease the risk of injury due to syncope. Persons with severe egg allergy should be vaccinated under the supervision of a medical provider who is able to recognize and manage severe allergic conditions.

Timing of Influenza Campaigns

Health-care providers should begin offering vaccination soon after the vaccine becomes available, and if possible, by October.

Flu Vaccine from ACPHD

Each year, we distribute flu vaccine to providers who agree to certain guidelines about to whom they will administer the vaccine and how and when to report usage. Visit our Flu Vaccine Distribution Program page for more information.

Terms of Use  |  Privacy